Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies

Background and Aims: Statins are the first-line medication to treating hypercholesterolemia. Several studies have investigated the impact of statins on the risk of hepatocellular carcinoma (HCC). However, the extent to which statins may prevent HCC remains uncertain. Therefore, we performed a meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Md. Mohaimenul, Poly, Tahmina Nasrin, Walther, Bruno Andreas, Yang, Hsuan-Chia, Li, Yu-Chuan (Jack)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139959/
https://www.ncbi.nlm.nih.gov/pubmed/32183029
http://dx.doi.org/10.3390/cancers12030671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139959/
https://www.ncbi.nlm.nih.gov/pubmed/32183029
http://dx.doi.org/10.3390/cancers12030671

Ejemplares similares